CXCR4 RECEPTOR ANTAGONISTS

PROBLEM TO BE SOLVED: To provide a novel compound having CXCR4 antagonist action and useful for the treatment of diseases such as cancer, cancer metastasis, HIV/AIDS, neuropathy, HIV related neuropathy, brain inflammation, diabetic retinopathy, age-related macular degeneration, and retinal neovascul...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GILES BROWN, KATHRYN OLIVER, LEE PATIENT, ALISON STEWART, ANDREW GRAHAM COLE, IAIN SIMPSON, ALISON CARLEY, MICHAEL HIGGINBOTTOM, EDWARD DANIEL SAVORY
Format: Patent
Sprache:eng ; jpn
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:PROBLEM TO BE SOLVED: To provide a novel compound having CXCR4 antagonist action and useful for the treatment of diseases such as cancer, cancer metastasis, HIV/AIDS, neuropathy, HIV related neuropathy, brain inflammation, diabetic retinopathy, age-related macular degeneration, and retinal neovascularization.SOLUTION: The present invention provides a compound of formula (I), where Ris a heterocycle-carbamoyl group such as pyridine-4-ylcarbamoyl; Ris an optionally substituted heterocyclic group such as 1-isopropylpiperidine-4-yl; X is a 5 or 6 membered aromatic heterocyclic diyl group such as pyridine-2,6-diyl; Y is a heterocyclic diyl group such as homopiperazine-1,4-diyl.SELECTED DRAWING: None 【課題】CXCR4アンタゴニスト作用を有し、癌、癌の転移、HIV/AIDS、神経障害、HIV関連神経障害、脳炎症、糖尿病性網膜症、加齢黄斑変性、網膜血管新生等の疾患の治療に有用な新規化合物の提供。【解決手段】下記式(I)で表される化合物。(R1はピリジン−4−イルカルバモイル等の複素環−カルバモイル基;R2は1−イソプロピルピペリジン−4−イル等の置換可複素環基;Xはピリジン−2,6−ジイル等の5又は6員の芳香複素環ジイル基;Yはホモピペラジン−1,4−ジイル等の複素環ジイル基等。)【選択図】なし